Pfizer Sells 49% Stake in China-Hisun Generic Drug JV

22:15 EST 13 Nov 2017 | ChinaBio Today

Pfizer has sold its 49% stake in a China generic drug JV it formed five years ago with Zhejiang Hisun Pharma. The company sold the stake to Sapphire I Holdings at an undisclosed price. In 2016, Pfizer signaled it intended to end the partnership because the JV's profits had not lived up to expectations. In 2012, when the JV was formed, it was said to be worth $545 million, with both companies contributing assets to the JV, not cash. More details....

Stock Symbols: (NYSE: PFE) (SHA: 600267)

Share this with colleagues:

Original Article: Pfizer Sells 49% Stake in China-Hisun Generic Drug JV


More From BioPortfolio on "Pfizer Sells 49% Stake in China-Hisun Generic Drug JV"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...